Novozymes A/S
F:NZM2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novozymes A/S
F:NZM2
|
DK |
|
P
|
Paycom Software Inc
F:0PY
|
US |
|
Sinopec Oilfield Service Corp
OTC:YZCFF
|
CN |
|
S
|
Sinopec Oilfield Service Corp
XMUN:YIZH
|
CN |
|
L
|
Landstar System Inc
SWB:LDS
|
US |
|
R
|
Rio Tinto PLC
F:RIO1
|
UK |
|
Nurexone Biologic Inc
OTC:NRXBF
|
CA |
Wall St Price Targets
NZM2 Price Targets Summary
Novozymes A/S
According to Wall Street analysts, the average 1-year price target for NZM2 is 62.09 EUR with a low forecast of 50.55 EUR and a high forecast of 77.44 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NZM2's stock price target?
Price Target
62.09
EUR
According to Wall Street analysts, the average 1-year price target for NZM2 is 62.09 EUR with a low forecast of 50.55 EUR and a high forecast of 77.44 EUR.
What is the Revenue forecast for Novozymes A/S?
Projected CAGR
-55%
Over the last 7 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 2 years is -55%.
What is the Net Income forecast for Novozymes A/S?
Projected CAGR
-56%
Over the last 7 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 2 years is -56%.
